Frontlight ResearchEarly access
Trial site
Accel Research Sites - Maitland
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Depression2 trials
- Diabetic neuropathy1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 36 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Completed4 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.3 trials
- Corium, Inc.2 trials
- Cybin IRL Limited2 trials
- Eli Lilly and Company1 trial
- Vertex Pharmaceuticals Incorporated1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Enrolling by invitation
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026